Patent · US Active

Heterodimeric immunoglobulins

US10233237B2 · kind B2 · utility

3Cited by
62References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 21, 2013
Grant dateMar 19, 2019
Priority date—
Expiry dateJun 14, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present application is directed to heterodimeric antibodies and methods of use.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.